Bret Wilshere

Analysts Concerns on: Barclays PLC (ADR) (NYSE:BCS)

Barclays PLC (ADR) (NYSE:BCS) rose 0.09% during previous trade. Morgan Stanley issued rating on the stock of Barclays PLC (ADR) (NYSE:BCS) in a research note issued to investors on Mar-17-17, the stock received “Upgrade” rating from Equal-Weight to Overweight. Additionally Berenberg issued their verdict on the stock of the company, on record date of Jan-30-17 the stock was “Downgraded” from Hold to Sell besides that on Jan-12-17 Barclays PLC (ADR) (NYSE:BCS) was “Downgraded” by Macquarie from Outperform to Neutral. Furthermore on Dec-09-16 the stock was “Downgraded” by BofA/Merrill from Neutral to Underperform.

Barclays PLC (ADR) (NYSE:BCS) shares ended last trading session at the price of $11.37 whereas a number of traders indicating mean target price will hit $9.66 over the next twelve months, mean value of price target most recently revised on 02/28/17. Barclays PLC (ADR) (NYSE:BCS)’s highest estimates of price target are $9.99 and low forecast is $9.33 based on the opinion of 2 analysts. The price target estimates represents a standard deviation of 0.00. However brokerage recommendations suggests an ABR of 2.80 based on calls of 5 experts, where 1 brokers polls the stock a Strong Buy, 0 suggest the stock a Buy, 3 suggest Hold, 0 are rating the stock as Sell while 1 as Strong Sell.

Barclays PLC (ADR) (NYSE:BCS)’s average revenue estimates for the current quarter are $27.82B according to 1 analyst. However its lowest revenue estimates are $27.82B and highest revenue estimates are $27.82B. A year ago the company’s sales were $29.17B. Its yearly sales growth estimates are -4.60%. For the next quarter the company has anticipated average revenues of $27.82B, according to the sentiments of 1 analyst. For the current year the company has fixed $27.82B revenues, as per the opinion of 1 analyst. For the current year the company has low revenue estimates of $27.82B in contradiction of high revenue estimates of $27.82B. Whereas for the next year revenues are set at $29.73B by 1 analyst.

The stock exchanged hands 3.34M shares versus average trading capacity of 3.04M shares, while its shares’ total market worth is $49.15B along with 16.96B outstanding shares. Barclays PLC (ADR) (NYSE:BCS) shares were trading -4.79% below from the 52-week high price mark of $11.94 and +70.78% above from the 52-week price bottom of $6.66. However the company observed 52 week high price on 12/08/16 and witnessed 52 week low price on 06/27/16. The company’s price sits 0.63% above from its 50-day moving average of $11.36 and 17.32% far from the stock’s 200-day moving average which is $10.32. Barclays PLC (ADR) (NYSE:BCS)’s price to sales ratio for trailing twelve month stands at 55, whereas its price to book ratio for most recent quarter sits at 3.78. However the company’s price to cash per share for most recent quarter stands at 0.61. Its price to free cash flow for trailing twelve months is 0.06.

Analyst’s Ratings Review: L Brands Inc (NYSE:LB)

L Brands Inc (NYSE:LB) rose 2.42% during previous trade. FBR & Co. issued rating on the stock of L Brands Inc (NYSE:LB) in a research note issued to investors on Mar-17-17, the stock received “Upgrade” rating from Mkt Perform to Outperform. Additionally Telsey Advisory Group issued their verdict on the stock of the company, on record date of Feb-24-17 the stock was “Reiterated” as Outperform from $83 to $60 besides that on Feb-24-17 L Brands Inc (NYSE:LB) was “Reiterated” by Mizuho as Neutral from $62 to $51. Furthermore on Feb-23-17 the stock was “Reiterated” by UBS as Neutral from $64 to $52.

L Brands Inc (NYSE:LB) shares ended last trading session at the price of $51.18 whereas a number of traders indicating mean target price will hit $54.33 over the next twelve months, mean value of price target most recently revised on 03/15/17. L Brands Inc (NYSE:LB)’s highest estimates of price target are $70 and low forecast is $40 based on the opinion of 24 analysts. The price target estimates represents a standard deviation of 8.51. However brokerage recommendations suggests an ABR of 2.59 based on calls of 22 experts, where 5 brokers polls the stock a Strong Buy, 1 suggest the stock a Buy, 14 suggest Hold, 0 are rating the stock as Sell while 2 as Strong Sell.

L Brands Inc (NYSE:LB) is expected to release the earnings of its current quarter on 5/17/17. The company is expected to release $0.25 EPS for current quarter according to 28 analysts whereas the company reported $0.59 EPS during same quarter a year ago. For the current quarter the stock has lowest EPS estimates of $0.2 and high estimate of $0.29. For the current year L Brands Inc (NYSE:LB) has set to release EPS of $3.2 as per the sentiments of 30 analysts, however according to 28 analysts, the company expected to release $3.46 EPS for next year.

L Brands Inc (NYSE:LB)’s average revenue estimates for the current quarter are $2.45B according to 26 number of analysts. However its lowest revenue estimates are $2.37B and highest revenue estimates are $2.59B. A year ago the company’s sales were $2.61B. Its yearly sales growth estimates are -6.20%. For the next quarter the company has anticipated average revenues of $2.78B, according to the sentiments of 26 analysts. For the current year the company has fixed $12.57B revenues, as per the opinion of 28 analysts. For the current year the company has low revenue estimates of $12.17B in contradiction of high revenue estimates of $12.84B. Whereas for the next year revenues are set at $13.01B by 26 analysts.

The stock exchanged hands 10.29M shares versus average trading capacity of 4.68M shares, while its shares’ total market worth is $14.43B along with 285.96M outstanding shares. L Brands Inc (NYSE:LB) shares were trading -40.23% below from the 52-week high price mark of $85.63 and +6.78% above from the 52-week price bottom of $47.93. However the company observed 52 week high price on 03/18/16 and witnessed 52 week low price on 02/23/17. The company’s price sits -9.91% below from its 50-day moving average of $55.22 and -23% away from the stock’s 200-day moving average which is $66.03. L Brands Inc (NYSE:LB)’s price to sales ratio for trailing twelve month stands at 1.43, whereas its price to book ratio for most recent quarter sits at 1.16.

Analyst’s keeping an Eye on:General Electric Company (NYSE:GE)

General Electric Company (NYSE:GE) share price soared 0.44% or 0.13 points to reach at $29.88 during previous trading session. The stock’s price fluctuated within the range of $29.77– $30.04 during previous trading session. A total of 43.64M shares exchanged hands, whereas the company’s average trading volume stands at 28.54M shares. General Electric Company (NYSE:GE) has a market capitalization of $261.27B and most recently 8.71B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for General Electric Company (NYSE:GE) is at 46.98.

According to sentiments of 15 analysts the mean estimates of short term price target for the company’s stock is marked at $33.60. The most optimistic analyst sees the stock reaching $38 while the most conventional predicts the target price at $28.

The consensus mean EPS for the current quarter is at $0.18 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.16 and can go high up to $0.27. However a year ago during same quarter General Electric Company (NYSE:GE) reported $0.21 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.31 per share according to consensus of 15 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $26.47B for the current quarter. Bearish revenue estimates established at $25.82B while the bullish revenue forecast has been figured out at $27.1B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.06 on the shares of General Electric Company (NYSE:GE). Out of rating recommendations 7 have given the stock a Buy while 4 recommend the stock as Outperform. 6 have given the stock a Hold rating, 1 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. General Electric Company (NYSE:GE)’s distance from 20 day simple moving average is -0.35% whereas its distance from 50 day simple moving average is -0.82% along with -0.71% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. General Electric Company (NYSE:GE) shares were trading -7.33% below from the 52-week high mark of $32.24 and +7.64% above from the 52-week bottom of $27.76. The stock hit its 52-week high price on 7/20/16 and 52-week low price on 11/03/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -1.32% in the past one week and plunged -0.76% during previous one month drive, the stock went down -3.67% during past quarter. In the last six months the stock’s performance advanced 2% while yearly performance of the company fell -0.47%. The company’s year to date (YTD) performance is at -4.69%.

While taking a glance at financials, we can look at a number of key indicators. General Electric Company (NYSE:GE) has a Return on Assets (ROA) of 2%. The company currently has a Return on Equity (ROE) of 9.80% and a Return on Investment (ROI) of 5.10%. Average true range (ATR-14) of the company sets at 0.32, along with its weekly and monthly volatility of 1.09%, 1.03% respectively. Beta value of the stock stands at 1.18.

The company’s total debt to equity ratio of the company for most recent quarter is 1.80 whereas long term debt to equity ratio for most recent quarter is 1.39.

Brokerage Recommendations on Rating: Chicago Bridge & Iron Company N.V. (NYSE:CBI)

Chicago Bridge & Iron Company N.V. (NYSE:CBI) fell -2.11% during previous trade. Argus issued rating on the stock of Chicago Bridge & Iron Company N.V. (NYSE:CBI) in a research note issued to investors on Mar-17-17, the stock received “Downgrade” rating from Buy to Hold. Additionally Argus issued their verdict on the stock of the company, on record date of Dec-07-16 the stock was “Initiated” as Buy at $43 besides that on Sep-21-16 Chicago Bridge & Iron Company N.V. (NYSE:CBI) was “Downgraded” by Johnson Rice from Buy to Hold. Furthermore on Jul-28-16 the stock was “Reiterated” by MKM Partners as Buy from $46 to $42.

Chicago Bridge & Iron Company N.V. (NYSE:CBI) shares ended last trading session at the price of $29.76 whereas a number of traders indicating mean target price will hit $36.36 over the next twelve months, mean value of price target most recently revised on 03/10/17. Chicago Bridge & Iron Company N.V. (NYSE:CBI)’s highest estimates of price target are $46 and low forecast is $18 based on the opinion of 14 analysts. The price target estimates represents a standard deviation of 6.12. However brokerage recommendations suggests an ABR of 2.55 based on calls of 11 experts, where 4 brokers polls the stock a Strong Buy, 0 suggest the stock a Buy, 5 suggest Hold, 1 are rating the stock as Sell while 1 as Strong Sell.

Chicago Bridge & Iron Company N.V. (NYSE:CBI) is expected to release the earnings of its current quarter on 4/19/17. The company is expected to release $0.94 EPS for current quarter according to 13 analysts whereas the company reported $1.01 EPS during same quarter a year ago. For the current quarter the stock has lowest EPS estimates of $0.72 and high estimate of $1.05. For the current year Chicago Bridge & Iron Company N.V. (NYSE:CBI) has set to release EPS of $4.2 as per the sentiments of 12 analysts, however according to 14 analysts, the company expected to release $4.56 EPS for next year.

Chicago Bridge & Iron Company N.V. (NYSE:CBI)’s average revenue estimates for the current quarter are $2.43B according to 13 number of analysts. However its lowest revenue estimates are $2.18B and highest revenue estimates are $2.54B. A year ago the company’s sales were $2.67B. Its yearly sales growth estimates are -9%. For the next quarter the company has anticipated average revenues of $2.44B, according to the sentiments of 13 analysts. For the current year the company has fixed $10B revenues, as per the opinion of 10 analysts. For the current year the company has low revenue estimates of $9.68B in contradiction of high revenue estimates of $10.19B. Whereas for the next year revenues are set at $10.05B by 12 analysts.

The stock exchanged hands 3.19M shares versus average trading capacity of 1.74M shares, while its shares’ total market worth is $2.97B along with 100.31M outstanding shares. Chicago Bridge & Iron Company N.V. (NYSE:CBI) shares were trading -27.35% below from the 52-week high price mark of $40.97 and +14.73% above from the 52-week price bottom of $25.94. However the company observed 52 week high price on 04/28/16 and witnessed 52 week low price on 09/21/16. The company’s price sits -9.25% above from its 50-day moving average of $32.95 and -8.30% away from the stock’s 200-day moving average which is $31.36. Chicago Bridge & Iron Company N.V. (NYSE:CBI)’s price to sales ratio for trailing twelve month stands at 0.28, whereas its price to book ratio for most recent quarter sits at 2.11. However the company’s price to cash per share for most recent quarter stands at 5.90. Its price to free cash flow for trailing twelve months is 5.20.

Momentum Stock: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.32% or -0.11 points to reach at $34.32 during previous trading session. The stock’s price fluctuated within the range of $34.27 – $34.58 during previous trading session. A total of 43.39M shares exchanged hands, whereas the company’s average trading volume stands at 25.10M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $202.55B and most recently 5.96B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 63.00.

According to sentiments of 19 analysts the mean estimates of short term price target for the company’s stock is marked at $38.000. The most optimistic analyst sees the stock reaching $52.00 while the most conventional predicts the target price at $33.00.

The consensus mean EPS for the current quarter is at $0.67 derived from a total of 12 estimates. According to analysts minimum EPS for the current quarter is expected at $0.62 and can go high up to $0.72. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.67 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 12 analysts.

According to sentiments of 11 analysts the company is expected to report revenues of $13.13B for the current quarter. Bearish revenue estimates established at $12.86B while the bullish revenue forecast has been figured out at $13.38B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc.(NYSE:PFE)’s distance from 20 day simple moving average is +0.58% whereas its distance from 50 day simple moving average is +4.37% along with +3.65% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading –5.57% below from the 52-week high mark of $36.35 and +23.95% above from the 52-week bottom of $27.69. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 03/18/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 0.62% in the past one week and soared 2.42% during previous one month drive, the stock went up 5.64% during past quarter. In the last six months the stock’s performance soared 2.56% while yearly performance of the company advanced 21.41%.The company’s year to date (YTD) performance is at 6.74%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 4.20%. The company currently has a Return on Equity (ROE) of 11.60% and a Return on Investment (ROI) of 7.80%.Average true range (ATR-14) of the company sets at 0.40, along with its weekly and monthly volatility of 1.05%, 1.15% respectively. Beta value of the stock stands at 0.97.

The company’s price to free cash flow for trailing twelve months is 31.64. Its quick ratio for most recent quarter is 1.00 along with current ratio for most recent quarter of 1.30. Total debt to equity ratio of the company for most recent quarter is 0.71 whereas long term debt to equity ratio for most recent quarter is 0.53.

Celsion Corporation (NASDAQ:CLSN) to Report Quarterly Earnings: What’s in the Cards?

Shares of Celsion Corporation (NASDAQ:CLSN) jumped 3.45% to reach at $0.30 during previous trading session. The company has experienced volume of 15,084,709 shares while on average the company has a capacity of trading 2.65M share.

Celsion Corporation (NASDAQ:CLSN) an oncology drug development company, on March 16, 2017 announced financial results for the year ended December 31, 2016 and provided an update on its development programs for ThermoDox, its proprietary heat-activated liposomal encapsulation of doxorubicin and GEN-1, an IL-12 DNA plasmid vector encased in a nanoparticle delivery system, which enables cell transfection followed by persistent, local secretion of the IL-12 protein.  The Company’s lead program is ThermoDox which is currently in Phase III development for the treatment of primary liver cancer and in Phase II development for the treatment of recurrent chest wall breast cancer. The Company’s immunotherapy program consists of GEN-1 and is currently in Phase I development for the localized treatment of ovarian cancer.

“Celsion had an exceedingly productive 2016 as our accomplishments, one after another, established meaningful progress with respect to our two leading-edge technology platforms designed to enhance clinically powerful therapies. With sound fundamentals, the superb execution of our ongoing global, pivotal Phase III OPTIMA Study in primary liver cancer, continues to attract interest and support from the medical community, international regulatory agencies, and research organizations like the National Institutes of Health for this ground-breaking study,” said Michael H. Tardugno, Celsion’s chairman, president and CEO. “Our efforts in immuno-oncology are equally important. Over the past year, we have demonstrated the potential of our GEN-1 program to be an effective adjuvant, in both first and second-line ovarian cancer. Recruiting the immune system to work in combination with the standard of care in this patient population has been the goal of medical researchers worldwide.  With GEN-1, we believe there is the potential for a break-through and we look forward to reporting comprehensive clinical findings and translational data from our nearly complete OVATION Study in the first half of 2017.”

Celsion Corporation (NASDAQ:CLSN) holds the market capitalization of $10.26M along with 31.20M outstanding shares. During the last trade, stock’s minimum price has been reached out at $0.30 while the maximum trading price moved at $0.37. Currently the stock price is moving -83.15% off from the highest level of twelve months and +62.16% above from twelve months low. Celsion Corporation (NASDAQ:CLSN) marked 52-week highest price level of $1.78 on 04/19/16 and 52-week lowest price level of $0.19 on 02/15/17. For the stock, price target value has been calculated at $3.00 based on calls of 2 experts. Stock’s minimum price target estimates has been figured out at $3.00 while the maximum price target forecast is established at $3.00.

As of current trade, Celsion Corporation (NASDAQ:CLSN) has shown weekly downbeat performance of -9.09%. Its six months performance indicated a bearish movement while its yearly performance reflected a negative trend of -77.27%. Year-to-date (YTD) performance of the stock illustrate downbeat trend of -1.28%. Shares of Celsion Corporation (NASDAQ:CLSN) currently have an ABR of 1.67, derived from a total of 3 opinions. The company’s price sits -6.62% below from its 50-day moving average of $0.30 and -66.50% above below from the stock’s 200-day moving average of $0.71. The company has Relative Strength Index (RSI 14) of 50.51 along with Average True Range (ATR 14) of 0.05. Its weekly and monthly volatility is 20.59%, 14.92% respectively. The company’s beta value is at 1.26.

Celsion Corporation (NASDAQ:CLSN)’s price to sales ratio for trailing twelve months is 23.36 and price to book ratio for most recent quarter is 0.79, whereas price to cash per share for the most recent quarter is 1.34. Celsion Corporation (NASDAQ:CLSN)’s quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 0.90. Total debt to equity ratio of the company for most recent quarter is 0.34 whereas long term debt to equity ratio for most recent quarter is 0.00. Celsion Corporation (NASDAQ:CLSN) has a Return on Assets of -51.20%. The company currently has a Return on Equity of -141.30%.

Analysts Concerns on: Edison International (NYSE:EIX)

Edison International (NYSE:EIX) plunged -0.74% during previous trade, a total of 1.54M shares exchanged hands compared with its average trading volume of 1.95M shares whereas its relative volume is 0.90. The stock has a market capitalization of $26.25B along with 325.81M outstanding shares. Stock’s intraday price range hit the peak level of $79.61 and touched the lowest level of $78.90.

Most recently Edison International (NYSE:EIX)’s price target was revised on 03/09/17 and according to 16 analysts stock’s price will reach at $80.77 during 52 weeks with standard deviation of 2.73. Stock’s minimum price target estimates has been figured out at $75 while the maximum price target forecast is established at $86, if we look at the price target with an optimistic approach it has upside potential of 86% from its latest closing price of $79.18.

Historically, if we look at price target revisions, one week ago Edison International (NYSE:EIX)’s price target was revised on 3/5/17 by the analysts, however the bullish price estimates of the stock set at $86 while the bearish estimates kept at $77 over the next one year. Stock’s 52-week target was retained at $81.17, the estimates indicates a standard deviation of 3.31.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 1.89. ABR value is precisely based on brokerage recommendations, where out of 9 brokerage recommendations 5 rate Edison International (NYSE:EIX) stock a Strong Buy, 0 rate the stocks of the company a Buy, 4 rate Hold, 0 rate Sell and 0 recommend a Strong Sell. Most recently on 4/1/16 the stock of Edison International (NYSE:EIX) upgraded by Goldman from Buy to Neutral. However previously on 11/6/15 it was upgraded by Wolfe Research from Peer Perform to Outperform. A research note issued on 10/29/15 the stock was downgraded by Citigroup from Buy to Neutral.

Edison International (NYSE:EIX) performance over the past one year soared 15.11% whereas its year to date (YTD) performance indicated a bullish trend of 9.99%. During the last six months the stock climbed 11.79%. Quarterly performance of the company shows optimistic momentum of 12.10% while its last one month trend is positive with 5.03%. Stock’s weekly performance expressed up trend of 1.51%.

The company’s price sits 5.73% above from its 50-day moving average of $75.88 and 8.75% far from the stock’s 200-day moving average which is $72.48. Edison International (NYSE:EIX)’s shares are currently trading -1.77% away from the 52-week high price of $80.61 and +19.35% far from the 52-week low price of $66.35.

According to consensus agreement of 11 analysts Edison International (NYSE:EIX) will report earnings per share of $0.94 in their quarterly report and it is expected to announce the company’s results on 5/1/17. For the current quarter the company has high EPS estimates of $1.44 in contradiction of low EPS estimates of $0.8. However a year ago for the same quarter the company has reported $0.82 EPS. Current year EPS projections for Edison International (NYSE:EIX) set at $4.13 according to the sentiments of 18 analysts, while its lowest earnings estimates are $4.06 and highest earnings estimates are $4.2.

According to 6 analysts, Edison International (NYSE:EIX)’s revenue estimates for the current quarter are $2.73B meanwhile the company has high revenue estimates of $2.94B in contradiction of low revenue estimates of $2.5B. For the current year the company’s revenue estimates are $12.34B compared to low analyst estimates of $11.36B and high estimates of $12.96B according to the projection of 12 analysts.

Analyst’s Review to Watch: CVS Health Corp (NYSE:CVS)

CVS Health Corp (NYSE:CVS) plunged -1.02% during previous trade, a total of 6.22M shares exchanged hands compared with its average trading volume of 6.99M shares whereas its relative volume is 0.93. The stock has a market capitalization of $81.44B along with 1.03B outstanding shares. Stock’s intraday price range hit the peak level of $79.98 and touched the lowest level of $79.23.

Most recently CVS Health Corp (NYSE:CVS)’s price target was revised on 3/7/17 and according to 23 analysts stock’s price will reach at $86.52 during 52 weeks with standard deviation of 9.09. Stock’s minimum price target estimates has been figured out at $66.90 while the maximum price target forecast is established at $96, if we look at the price target with an optimistic approach it has upside potential of 20% from its latest closing price of $79.56.

Historically, if we look at price target revisions, three weeks ago CVS Health Corp (NYSE:CVS)’s price target was revised on 2/10/17 by the analysts, however the bullish price estimates of the stock set at $120 while the bearish estimates kept at $77 over the next one year. Stock’s 52-week target was retained at $91.35, the estimates indicates a standard deviation of 10.47.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 1.79. ABR value is precisely based on brokerage recommendations, where out of 19 brokerage recommendations 11 rate CVS Health Corp (NYSE:CVS) stock a Strong Buy, 1 rate the stocks of the company a Buy, 7 rate Hold, 0 rate Sell and 0 recommend a Strong Sell. Most recently on 2/6/17 the stock of CVS Health Corp (NYSE:CVS) downgraded by Atlantic Equities from Overweight to Neutral. However previously on 2/2/17 it was downgraded by Robert W. Baird from Outperform to Neutral. A research note issued on 12/12/16 the stock was downgraded by Jefferies from Buy to Hold.

CVS Health Corp (NYSE:CVS) performance over the past one year plunged -19.66% whereas its year to date (YTD) performance indicated a bullish trend of 1.43%. During the last six months the stock slipped -10.07%. Quarterly performance of the company shows declining momentum of -0.14% while its last one month trend is positive with 1.13%. Stock’s weekly performance expressed down trend of -1.41%.

The company’s price sits -0.54% below from its 50-day moving average of $79.28 and -7.45% below from the stock’s 200-day moving average which is $82.43. CVS Health Corp (NYSE:CVS)’s shares are currently trading -24.26% away from the 52-week high price of $105.04 and +15.50% far from the 52-week low price of $68.88.

According to consensus agreement of 21 analysts CVS Health Corp (NYSE:CVS) will report earnings per share of $1.1 in their quarterly report and it is expected to announce the company’s results on 5/2/17. For the current quarter the company has high EPS estimates of $1.13 in contradiction of low EPS estimates of $1.09. However a year ago for the same quarter the company has reported $1.18 EPS. Current year EPS projections for CVS Health Corp (NYSE:CVS) set at $5.86 according to the sentiments of 23 analysts, while its lowest earnings estimates are $5.8 and highest earnings estimates are $5.95.

According to 18 analysts, CVS Health Corp (NYSE:CVS)’s revenue estimates for the current quarter are $44.23B meanwhile the company has high revenue estimates of $45.4B in contradiction of low revenue estimates of $43.93B. For the current year the company’s revenue estimates are $184.26B compared to low analyst estimates of $183.26B and high estimates of $189.33B according to the projection of 20 analysts.

Momentum Stock in Focus: Intrepid Potash, Inc. (NYSE:IPI)

Intrepid Potash, Inc. (NYSE:IPI) share price plunged -1.41% or -0.02 points to reach at $1.40 during previous trading session. The stock’s price fluctuated within the range of $1.24 – $1.42 during previous trading session. A total of 8.06M shares exchanged hands, whereas the company’s average trading volume stands at 1.69M shares. Intrepid Potash, Inc. (NYSE:IPI) has a market capitalization of $111M and most recently 79.28M outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Intrepid Potash, Inc. (NYSE:IPI) is at 28.26.

According to sentiments of 2 analysts the mean estimates of short term price target for the company’s stock is marked at $2. The most optimistic analyst sees the stock reaching $2 while the most conventional predicts the target price at $2.

The consensus mean EPS for the current quarter is at $-0.09 derived from a total of 5 estimates. According to analysts minimum EPS for the current quarter is expected at $-0.1 and can go high up to $-0.07. However a year ago during same quarter Intrepid Potash, Inc. (NYSE:IPI) reported $-0.22 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $-0.08 per share according to consensus of 5 analysts.

According to sentiments of 2 analysts the company is expected to report revenues of $36.48M for the current quarter. Bearish revenue estimates established at $35.55M while the bullish revenue forecast has been figured out at $37.4M.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 3.40 on the shares of Intrepid Potash, Inc. (NYSE:IPI). Out of rating recommendations 0 have given the stock a Buy while 0 recommend the stock as Outperform. 3 have given the stock a Hold rating, 2 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Intrepid Potash, Inc. (NYSE:IPI)’s distance from 20 day simple moving average is -28.90% whereas its distance from 50 day simple moving average is -30.29% along with -9.94% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Intrepid Potash, Inc. (NYSE:IPI) shares were trading -53.95% below from the 52-week high mark of $3.04 and +64.71% above from the 52-week bottom of $0.85. The stock hit its 52-week high price on 12/09/16 and 52-week low price on 05/09/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -23.08% in the past one week and plunged -36.65% during previous one month drive, the stock went down -34.58% during past quarter. In the last six months the stock’s performance soared 9.38% while yearly performance of the company advanced 10.24%.The company’s year to date (YTD) performance is at -32.69%.

While taking a glance at financials, we can look at a number of key indicators. Intrepid Potash, Inc. (NYSE:IPI) has a Return on Assets (ROA) of -11.30%. The company currently has a Return on Equity (ROE) of -17.20% and a Return on Investment (ROI) of -11.40%. Average true range (ATR-14) of the company sets at 0.17, along with its weekly and monthly volatility of 11.77%, 9.07% respectively. Beta value of the stock stands at 1.27.

The company’s quick ratio for most recent quarter is 1.20 along with current ratio for most recent quarter of 5.10. Total debt to equity ratio of the company for most recent quarter is 0.00 whereas long term debt to equity ratio for most recent quarter is 0.37.

Tiffany & Co. (NYSE:TIF): What to Expect From Earnings?

Tiffany & Co. (NYSE:TIF) plunged -0.04% or -0.04 points during previous trade after opening at the price of $89.98, a total of 2,269,449 shares exchanged hands compared with its average trading volume of 1.86M shares. The stock has a market capitalization of $11.37B and it has 124.50M outstanding shares.

According to consensus agreement of 22 analysts Tiffany & Co. (NYSE:TIF) will report earnings per share of $1.38 in their quarterly report and it is expected to announce the company’s results on 3/17/17 Before Market Open. The stock added almost 14.2% in price since last earning report, when its share price was $77.70. For the current quarter the company has highest EPS estimates of $1.43 and low forecast is $1.31. However a year ago for the same quarter the company has reported $1.46 earnings per share.

Earnings reaction history indicates that share price went up 20 times out of last 27 quarters. In Tiffany & Co. (NYSE:TIF)’s last 12 earnings reports, it has beaten EPS estimates 58% of the time. However it has meet the estimates 0 time and missed 5 times.

If we have a peek on EPS and surprise factor history during last four quarters, for the previous quarter ended on 10/2016, the consensus mean EPS was $0.67 while Tiffany & Co. (NYSE:TIF) reported $0.76 EPS on 11/29/2016 Before Market Open with a difference of 0.09 marking a surprise factor of 13.43%. The stock’s next day closing price was $80.15 with the gain of 3.15% in its share price. On seventh day of the earnings report price change of the stock was 6.53%.

Previously for the quarter ended on 7/2016, Tiffany & Co. (NYSE:TIF)’s expected mean EPS was $0.71, the company reported its quarterly earnings per share of $0.84 on 8/25/2016 Before Market Open, beating the analysts’ consensus estimate by 0.13 with surprise factor of 18.31%. The stock’s closing price was $72.42 with the gain of 6.41% in its share price on the day following the earning announcement. However price change of the stock was 3.63% on seventh day of the earnings report.

Tiffany & Co. (NYSE:TIF)’s mean EPS estimate was $0.68 for the quarter ended on 4/2016, while it reported EPS of $0.64 on 5/25/2016 Before Market Open, missing the analysts’ consensus estimate by -0.04 with surprise factor of 5.88%. On next day when data was publically announced, the stock’s closing price was $62.68 with 0.06% gain in its share price. On seventh day of the earnings report price change of the stock was down -2.97%.

Back on 3/18/2016 the company’s estimated EPS value was $1.40 and it reported $1.46 earnings per share (EPS) for the quarter ended on 1/2016. The company posted a positive surprise factor of 4.29% by 0.06.

Average EPS forecast for the current year is $3.66 according to 21 analysts making projections for Tiffany & Co. (NYSE:TIF). The most expectant earnings per share estimate of the stock is set at $3.7 while the conservative estimates kept at $3.58 over the current year. Having a look at the historical EPS report, the company attained $3.83 EPS for the previous year. While revenue estimates for the current year is $3.99B, Tiffany & Co. (NYSE:TIF) setting the highest revenues estimates of $4.02B and indicating lowest revenues at $3.96B according to agreement of 24 number of analysts. Current quarter revenue movements show that, the company has set average revenue estimates of $1.22B covering forecast of 19 analysts. The company indicates a peak revenue level of $1.24B and $1.19B at bottom level.

Having a glance at growth estimates of the company, it has current quarter growth estimates of -5.50%. Its forecasts over growth are -4.40% during current year while analysts’ growth estimation for the next year is 5.70%. Past 5 years growth of Tiffany & Co. (NYSE:TIF) observed at 1.56%, and for the next five years the analysts that follow this company are expecting its growth at 7.61%.

Tiffany & Co. (NYSE:TIF) reached at $89.98 price level during last trade its distance from 20 days simple moving average is 1.08%, and its distance from 50 days simple moving average is 8.23% while it has a distance of 23.22% from the 200 days simple moving average. One year trading price range hit the peak level of $92.74 and touched the lowest level of $56.32. The company’s distance from 52-week high price is -2.98% and current price is above +59.76% from 52-week low price.